Anthem (Elevance Health) Skyrizi Prior Authorization

Navigating the Anthem (Elevance Health) Skyrizi prior authorization process requires precise understanding of payer-specific channels and clinical criteria. Klivira streamlines this workflow for your team.

For revenue cycle directors and prior authorization coordinators, managing specialty drug approvals like Skyrizi (risankizumab) with Anthem-licensed plans presents unique challenges. This guide outlines the specific pathways and considerations to optimize prior authorization submissions and reduce administrative burden.

Understanding Skyrizi (Risankizumab) for Anthem Members

Skyrizi, an IL-23 inhibitor (risankizumab) by AbbVie, is a specialty medication commonly prescribed for conditions such as plaque psoriasis, psoriatic arthritis, and Crohn's disease. Due to its nature as a high-cost specialty drug, Anthem-licensed plans require prior authorization to ensure medical necessity and appropriate utilization for their members.

Navigating Anthem's Prior Authorization Channels for Skyrizi

Anthem operating companies process prior authorizations for specialty drugs like Skyrizi through specific channels depending on whether the drug falls under the medical or pharmacy benefit. For medical-benefit submissions, providers typically use Availity Essentials or X12 278 transactions via clearinghouses. For pharmacy-benefit Skyrizi, submissions are routed through CarelonRx's provider PA system or via ePA partners like CoverMyMeds and Surescripts.

Accessing Anthem Medical Policies and Clinical Criteria for Skyrizi

Anthem-licensed plans publish medical policies and clinical utilization management guidelines through provider sites accessible via Availity. These policies outline the specific medical necessity criteria for drugs like Skyrizi. It is crucial to consult the state-specific Anthem medical policy index, referencing the exact policy number, plan-state context, and effective date for accurate submission.

Electronic Prior Authorization (ePA) with Anthem for Skyrizi

Anthem-licensed plans support various electronic prior authorization methods. X12 278 transactions are accepted for medical-benefit PAs through clearinghouses. For pharmacy-benefit Skyrizi, electronic submissions are facilitated via CarelonRx's integration with ePA platforms such as CoverMyMeds and Surescripts. Elevance Health has also participated in Da Vinci Project initiatives, signaling ongoing development in electronic data exchange for prior authorization.

Common Denial Reasons and Appeal Pathways for Skyrizi PA

Prior authorization denials for Skyrizi from Anthem often stem from reasons such as medical necessity disputes, insufficient clinical documentation, failure to meet step therapy requirements, or site-of-service mismatches. Denials are typically communicated via X12 277/835 transactions or Availity status updates. Appeals for standard medical PAs follow the Anthem operating-company appeals process outlined in their provider manuals, with peer-to-peer reviews often available.

Streamlining Skyrizi Prior Authorizations with Klivira

Klivira's platform automates the complex prior authorization workflow for specialty drugs like Skyrizi, integrating directly with your EMR and Anthem's submission channels. By leveraging intelligent automation and real-time connectivity, Klivira helps reduce manual effort, minimize errors, and accelerate decision times, allowing your team to focus on patient care rather than administrative bottlenecks.

Frequently asked questions

How do I submit a prior authorization for Skyrizi to Anthem?

For medical-benefit Skyrizi, submissions are typically made via Availity Essentials or X12 278 transactions. For pharmacy-benefit Skyrizi, utilize CarelonRx's provider PA system or ePA partners like CoverMyMeds and Surescripts, depending on the specific benefit coverage.

Where can I find Anthem's medical policies for Skyrizi?

Anthem medical policies and clinical utilization management guidelines for Skyrizi are published on provider sites accessed through Availity. Always refer to the specific state-licensed Anthem plan's policy index, noting the policy number and effective date.

Does Anthem accept electronic prior authorizations for Skyrizi?

Yes, Anthem accepts X12 278 transactions for medical-benefit PAs. For pharmacy-benefit Skyrizi, electronic submissions are supported through CarelonRx's integrations with ePA platforms such as CoverMyMeds and Surescripts.

What are common reasons Anthem might deny a Skyrizi prior authorization?

Common denial reasons include medical necessity not met, insufficient clinical documentation, failure to complete step therapy, and site-of-service mismatches. Ensure all required clinical information is submitted to support the request.

How do I appeal a denied Skyrizi prior authorization with Anthem?

Appeals for denied Skyrizi prior authorizations should follow the standard Anthem operating-company appeals process. This process is detailed in the provider manual for the specific Anthem-licensed plan, and peer-to-peer review options are typically available.